A new £6.4 million dual hybrid endovascular theatre suite at the Manchester Royal Infirmary (MRI) will transform the treatment of patients undergoing minimally invasive vascular and cardiac procedures. Only a few such facilities exist world-wide. JONATHAN BAILLIE reports.
On its formation in 1752, in a small house in the city centre, Manchester Royal Infirmary (MRI) had just 12 beds. Today, the MRI is a large, extremely busy teaching hospital for Manchester University’s Medical School, and a specialist regional centre for kidney and pancreas transplants, haematology, and sickle cell disease. Part of the Central Manchester University Hospitals NHS Foundation Trust (CMFT), the MRI’s Heart Centre is a major regional provider of cardiac services, specialising in cardiothoracic surgery and cardiology, while its A&E department sees around 145,000 patients annually.
The Infirmary has gained a strong reputation as a centre for vascular and cardiac services – increasingly being undertaken via endovascular, minimally invasive procedures. The clinical advantages include lower mortality, less blood loss, reduced pain, less scarring, and quicker recovery.
To support the use of pioneering surgical techniques, a new suite has been installed consisting of two hybrid theatres equipped with advanced technology, including a robotic C-arm with the ability to scan patients during surgery, allowing surgeons to perform delicate, minimally invasive procedures with high definition imaging. The improved imaging technology minimises the use of contrast dye needed to illuminate an area during surgery, increasing patient safety and efficiency.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
